NuvOx Receives $2M SBIR Grant for Pancreatic Cancer Diagnostic Development

NCI logo In addition to the company's innovation in oxygen therapeutics, NuvOx also has an active pipeline of diagnostics in development. The National Cancer Institute has awarded a $2M Small Business and Innovation Research grant to fund the development of a new strategy to detect pancreatic cancer. For more information, read here.